Literature DB >> 30948157

Piezo1 mediates neuron oxygen-glucose deprivation/reoxygenation injury via Ca2+/calpain signaling.

Ying-Ying Wang1, Hao Zhang2, Tao Ma2, Yan Lu3, Hou-Yun Xie2, Wei Wang2, Yu-Heng Ma2, Guan-Hua Li2, Yong-Wang Li4.   

Abstract

OBJECTIVE: We investigated whether Piezo1 could regulate oxygen-glucose deprivation/reoxygenation injury of neurons through Ca2+/calpain signaling.
METHODS: Piezo1 expression in rat brain cortex and PC12 cells were confirmed by immunohistochemistry, immunofluorescence and Western blotting. The effects of Yoda1 and GsMTx4 on OGD/R-induced decrease in cell viability, increase in cell apoptosis and activation of downstreaming Ca2+/calpain signaling were investigated. Furthermore, calpain signaling was inhibited by PD151746 to see whether Ca2+/calpain signaling participated in the neurotoxic effects of Piezo1 activation.
RESULTS: Piezo1 expression was increased in rat cerebral cortex after ischemia/reperfusion and in PC12 cells after OGD/R. Activation of Piezo1 by Yoda1 enhanced OGD/R-induced cell viability inhibition, apoptosis, increase intracellular calcium levels and enhanced calpain activity while GsMTx4 showed the opposite effects. The effects of Piezo1 activation on cell viability and apoptosis were reversed by PD151746.
CONCLUSION: Piezo1 could regulate neuron oxygen-glucose deprivation/reoxygenation injury via activation of Ca2+/calpain signaling.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Apoptosis; Ca(2+)/calpain signaling; Oxygen-glucose deprivation/reoxygenation; Piezo1

Year:  2019        PMID: 30948157     DOI: 10.1016/j.bbrc.2019.03.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Piezo1-Regulated Mechanotransduction Controls Flow-Activated Lymphatic Expansion.

Authors:  Dongwon Choi; Eunkyung Park; Roy P Yu; Michael N Cooper; Il-Taeg Cho; Joshua Choi; James Yu; Luping Zhao; Ji-Eun Irene Yum; Jin Suh Yu; Brandon Nakashima; Sunju Lee; Young Jin Seong; Wan Jiao; Chester J Koh; Peter Baluk; Donald M McDonald; Sindhu Saraswathy; Jong Y Lee; Noo Li Jeon; Zhenqian Zhang; Alex S Huang; Bin Zhou; Alex K Wong; Young-Kwon Hong
Journal:  Circ Res       Date:  2022-06-14       Impact factor: 23.213

2.  Mechanoreceptor Piezo1 Is Downregulated in Multiple Sclerosis Brain and Is Involved in the Maturation and Migration of Oligodendrocytes in vitro.

Authors:  Maria Velasco-Estevez; Nina Koch; Ilona Klejbor; Fionä Caratis; Aleksandra Rutkowska
Journal:  Front Cell Neurosci       Date:  2022-05-26       Impact factor: 6.147

3.  Excessive mechanical stress-induced intervertebral disc degeneration is related to Piezo1 overexpression triggering the imbalance of autophagy/apoptosis in human nucleus pulpous.

Authors:  Sheng Shi; Xing-Jian Kang; Zhi Zhou; Zhi-Min He; Shuang Zheng; Shi-Sheng He
Journal:  Arthritis Res Ther       Date:  2022-05-23       Impact factor: 5.606

4.  Piezo1 induced apoptosis of type II pneumocytes during ARDS.

Authors:  Guo-Peng Liang; Jing Xu; Li-Li Cao; Yi-Hua Zeng; Bai-Xu Chen; Jing Yang; Zhong-Wei Zhang; Yan Kang
Journal:  Respir Res       Date:  2019-06-11

Review 5.  Force Sensing by Piezo Channels in Cardiovascular Health and Disease.

Authors:  David J Beech; Antreas C Kalli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-19       Impact factor: 8.311

Review 6.  Channeling the Force: Piezo1 Mechanotransduction in Cancer Metastasis.

Authors:  Jenna A Dombroski; Jacob M Hope; Nicole S Sarna; Michael R King
Journal:  Cells       Date:  2021-10-20       Impact factor: 7.666

7.  Mechanosensitive Piezo1 channels mediate renal fibrosis.

Authors:  Xiaoduo Zhao; Yonglun Kong; Baien Liang; Jinhai Xu; Yu Lin; Nan Zhou; Jing Li; Bin Jiang; Jianding Cheng; Chunling Li; Weidong Wang
Journal:  JCI Insight       Date:  2022-04-08

8.  Agonist-induced Piezo1 activation promote mitochondrial-dependent apoptosis in vascular smooth muscle cells.

Authors:  Qing Yin; Guangyao Zang; Nannan Li; Chenchen Sun; Rongzeng Du
Journal:  BMC Cardiovasc Disord       Date:  2022-06-24       Impact factor: 2.174

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.